logo

For the Inventor, By the Inventor

Vienna, Austria

Savira Pharmaceuticals Gmbh

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 87.5


Forward Citations = 4

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Helmut Heinrich Buschmann (8 out of 59 patents)

silverMedal Stephen Cusack (8 out of 13 patents)

bronzeMedal Andrea Wolkerstorfer (8 out of 8 patents)

4.  Oliver Szolar (8 out of 8 patents)

5.  Norbert Handler (8 out of 9 patents)

6.  Sung-Sau So (6 out of 56 patents)

7.  Mark Smith (6 out of 52 patents)

8.  Ronald Charles Hawley (4 out of 57 patents)

9.  Achyutharao Sidduri (3 out of 33 patents)

10.  Tanja Schulz-Gasch (2 out of 33 patents)

11.  Robert James Weikert (2 out of 11 patents)

12.  Werner Neidhart (2 out of 79 patents)

13.  Franz-Ferdinand Roch (2 out of 2 patents)

14.  Zhuming Zhang (1 out of 29 patents)

15.  Bruno Giethlen (1 out of 23 patents)


8 patents:

1. 9827244 - Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease (2017-11-28),
2. 9505758 - Substituted 1,5-naphthyridines as endonuclease inhibitors (2016-11-29),
3. 9434745 - 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease (2016-09-06),
4. 9359351 - Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease (2016-06-07),
5. 9199987 - Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease (2015-12-01),
6. 9045486 - Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease (2015-06-02),
7. 8952039 - Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease (2015-02-10),
8. 8921388 - Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease (2014-12-30),
Company Overview
Savira Pharmaceuticals GmbH is a global pharmaceutical company focused on developing innovative therapeutic solutions for various health conditions. With a strong commitment to research and development, Savira Pharmaceuticals aims to improve the lives of patients worldwide through groundbreaking medicines and treatments. Visit our website to learn more about our offerings and partnerships.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#87 in Vienna

#383 in Austria

Vienna, AT
Vienna, Austria

Savira Pharmaceuticals Gmbh

Forward Citations = 4

20 inventors:

goldMedal Helmut Heinrich Buschmann (8 out of 59 patents)

silverMedal Stephen Cusack (8 out of 13 patents)

bronzeMedal Andrea Wolkerstorfer (8 out of 8 patents)

4.  Oliver Szolar (8 out of 8 patents)

5.  Norbert Handler (8 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Savira Pharmaceuticals Gmbh. Retrieved from https://idiyas.com/company/savira-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…